latest news releases from the newsroom
Sandvik AB Effects of Transition to International Financial Reporting Standards (IFRS)
SANDVIKEN, Sweden, March 31, 2005 (PRIMEZONE) -- As of 1 January 2005, Sandvik is applying the International Financial Reporting Standards (IFRS). In this document, the comparative figures from 1 January 2004 have been restated from the accounting principles applied previously, "Swedish GAAP," to IFRS. The interim report for the first quarter of 2005 will be the first financial report that Sandvik provides in accordance with IFRS.
FTS Wireless, Inc.
FTS Secures New Location Targeting Hispanic Wireless Users
TAMPA, Fla., March 31, 2005 (PRIMEZONE) -- FTS Wireless, Inc., a subsidiary of FTS Group, Inc. (OTCBB:FLIP), an operator of retail wireless locations that market and sell next-generation wireless products and services and operates Wi-Fi Hot Spots, today announced that it has secured a new retail wireless location in the Tampa, Florida market.
31E Cellular, Corp.
31E Cellular Ltd. Announces Return to Profit
CALGARY, Alberta, March 31, 2005 (PRIMEZONE) -- 31E Cellular, Ltd. (Pink Sheets:VGTV) a Nevada Corporation is pleased to announce a return to profit as of March 2005. This follows a period of investment and expansion, which saw the company move into 250% larger premises and increase its sales force by 30%.
MIV Therapeutics, Inc.
MIV Therapeutics Builds Strength of Drug-Delivery Technologies Program with Appointment of Dr. Dean-Mo Lui as Chief Scientist
VANCOUVER, British Columbia, March 31, 2005 (PRIMEZONE) -- MIV Therapeutics, Inc. (OTCBB:MIVT) a developer of next-generation biocompatible stent coatings and drug delivery technologies, today announced the addition of Dr. Dean-Mo Liu, Ph.D., to the post of Chief Scientist, Drug Delivery Technologies. The announcement was made by Alan Lindsay, Chairman and CEO of MIVT.
Crucell N.V.: Staf Van Reet to lead Galapagos Corporate Development
LEIDEN, The Netherlands, March 31, 2005 (PRIMEZONE) -- Galapagos, a genomics-based drug discovery company, announces that it has appointed Staf Van Reet as VP Corporate Development. Dr. Van Reet will be responsible for in-licensing (pre-)clinical compounds and building a clinical development team at Galapagos. With this appointment, Galapagos further enhances its drug discovery operations, which are predominantly aimed at developing breakthrough medicines for the bone and joint diseases -- osteoarthritis, osteoporosis and rheumatoid arthritis."We are very pleased to welcome Staf Van Reet on board during this exciting time for Galapagos," commented Onno van de Stolpe, CEO of Galapagos. "Staf's many years of experience in the successful discovery and development of medicines will be a valuable asset in furthering Galapagos' drug discovery activities and in building a first class clinical development program."
Tele2/UTA Integration Completed
NEW YORK and STOCKHOLM, Sweden, March 31, 2005 (PRIMEZONE) -- Tele2 AB, ("Tele2") (Nasdaq:TLTOA) (Nasdaq:TLTOB) (Stockholmsborsen: TEL2A and TEL2B) the leading alternative pan-European telecommunications company, today announced that it has completed the process of integrating UTA and Tele2 in Austria, according to plan. The merger has created Austria's leading alternative telecom operator in both the corporate and the residential markets. This new and efficient organization enables Tele2 to continue to provide the best prices in the market.
GulfMark Offshore, Inc.
GulfMark Offshore Reports Fourth Quarter 2004 Results
HOUSTON, March 31, 2005 (PRIMEZONE) -- GulfMark Offshore, Inc. (Nasdaq:GMRK) today announced net income of $8.9 million, or $0.44 per diluted share, on revenue of $41.4 million for the quarter ended December 31, 2004. This compares to net income of $1.0 million, or $0.05 per diluted share for the quarter ended December 31, 2003, on revenue of $34.2 million. The fourth quarter 2004 results include an income tax benefit of $4.8 million, or $0.24 per diluted share resulting mainly from the release of deferred tax liabilities related to a tax audit.
Biacore: Annual General Meeting April 28, 2005
UPPSALA, Sweden, March 31, 2005 (PRIMEZONE) -- Biacore International AB (SSE:BCOR) announces today its decision to invite the shareholders of Biacore International AB to an Annual General Meeting of shareholders on April 28, 2005. A notice of the AGM is attached.